MD Analytics Insight Syndication

Key Ontario prescribers anticipate 60% increase in generic prescribing

It's true - the 60% increase is amongst one sub-group of GP/FP participants in our newest study examining the topic of drug interchangeability, Bill 102 and the evolving role of the pharmacist.

Understanding the relevant factors influencing GP/FP prescribing and pharmacist dispensing is crucial in helping healthcare organizations formulate the way forward in an environment of reform.

Please continue …

__________________________________________________________________

The MD Analytics’ Insight Syndication – Interchangeability Study

How can you…

Better understand what happens to your prescriptions after they leave the physicians’ office
Enrich understanding of the current and emerging influences on final drug choice
Discover factors that influence prescription choice, interchangeability and final dispensing decisions
Understand GP/FP and pharmacist reactions to the pharmacist playing a greater role in patient education with “professional services”
Gather valuable input to prepare health education information, tools and programs

This study is designed to help you with these key questions to aid your planning. The study objectives include:

Overall

Examine prescription writing decision making, behaviors and potential behavior changes
Understand attitudes towards branded versus non-branded drugs
Understand the frequency of interchanges, why they occur and the extent to which the physician is aware of them
Uncover top of mind concerns about Bill 102

GP/FP Module

Understand the physician point of view on generic alternatives and interchangeability
Evaluate the decision criteria that go into a prescription/ generic drug choice
Solicit reactions concerning the pharmacist playing a greater role in patient professional services. Examples include chronic disease management, care plan implementation, medication adherence

Comprehensive Reports Now Available

Pharmacist Module

Reveal key statistics on prescriptions and factors influencing interchangeability
Identify how pharmacists feel about additional patient counseling and professional services responsibilities such as separate medication reviews
Examine the influence pharmacists have on final drug fulfillment and their interactions. Are “no substitutions” always respected?

Who can benefit from this study?

…Market research managers, product managers, brand managers, CHE managers, managers responsible for patient support

Seeking actionable information to aid planning and tool development
Searching for insights on new influencers on final drug choice
Looking for guidance from GP/FPs and pharmacists on key components of Bill 102

…Strategic Planners, market access managers, health economists

Preparing for changes in the regulatory environment
Looking to enrich their planning process

	Pharmacist Module	GP/FP Module	Together
Target participants	170 Ontario Based Pharmacist Approximately 200 Ontario Based Pharmacists +/-6.86% margin of error, 19 times out of 2	189 Ontario Based GP/FPs +/-7.1% margin of error, 19 times out of 20	Buy both modules and save 20%
Cost	$5,900	$5,900	$9,440

For more information or to order the study, please email
costomerservice@mdanalytics.ca or call 1-866-617-0741